Showing results (1631-1640 of 3,569) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|May 31, 2015
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trialsDominick J Angiolillo, Deepak L Bhatt, Ph Gabriel Steg, et al.Journal of Thrombosis and Thrombolysis|January 23, 2026
Toward platelet-count-adaptive anticoagulation in cancer thrombocytopenia: a standards-first, equity-aware proposalM VijayasimhaJournal of Thrombosis and Thrombolysis|April 19, 2020
The management of patients with acute ischemic stroke while on direct oral anticoagulants (DOACs): data from an Italian cohort and a proposed algorithmE Rota, L Testa, G Di Brigida, et al.Journal of Thrombosis and Thrombolysis|April 20, 2020
Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case reportBo Zhou, Jianqing She, Yadan Wang, et al.Journal of Thrombosis and Thrombolysis|April 20, 2020
Predictors for layered coronary plaques: an optical coherence tomography studyMakoto Araki, Taishi Yonetsu, Michele Russo, et al.Journal of Thrombosis and Thrombolysis|February 9, 2023
DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS networkKarlyn A Martin, Nicola Lancki, Celina Li, et al.Journal of Thrombosis and Thrombolysis|February 13, 2023
A retrospective evaluation of direct oral anticoagulant (DOAC) management strategies in patients with cancer on active chemotherapyEmmeline Tran, Lauren E LedbetterJournal of Thrombosis and Thrombolysis|September 18, 2012
Vitamin B12 level in peripheral arterial diseaseKatalin S Zsóri, Zoltán Csiki, Éva Katona, et al.Journal of Thrombosis and Thrombolysis|September 19, 2012
Alterations of fibrin network structure mediated by dermatan sulfateAna María Lauricella, María Mercedes Castañon, Lucía C Kordich, et al.Journal of Thrombosis and Thrombolysis|August 7, 2012
Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins HospitalKimberly L Carter, Michael B Streiff, Patricia A Ross, et al.Pageof 357